CLU and metabolic syndrome: Conversely, in primary OA, MetS upregulates critical factors, including ACAN, PANX3, CLU, and VAT1L, enhancing cartilage catabolism, inflammation, and extracellular matrix stiffness, mediated by the accumulation of advanced glycation end products (AGEs).